Imunon, Inc. Conversion of Stock, Shares Converted
Imunon, Inc. (IMNN) reported Conversion of Stock, Shares Converted of 4.40 million shares for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2019-08-14
- Imunon, Inc. conversion of stock, shares converted for the quarter ending 2019-06-30 was 4.40M shares.
- Imunon, Inc. conversion of stock, shares converted for the quarter ending 2019-03-31 was 5.21M shares.
- Imunon, Inc. conversion of stock, shares converted for the quarter ending 2013-12-31 was 0.00 shares.
- Imunon, Inc. conversion of stock, shares converted for the quarter ending 2013-09-30 was -9.39M shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted 1 month | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|---|---|
| 2019-06-30 | 4.40M shares 10-Q · filed 2019-08-14 | 4.40M shares 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | 5.21M shares 10-Q · filed 2019-05-15 | |||||
| 2013-12-31 | 0.00 shares derived: 10-Q 12 month − 10-K 9 month · filed 2014-08-07 | -9.39M shares derived: sum of 2 quarters · filed 2014-08-07 | 2.67M shares derived: sum of 3 quarters · filed 2014-08-07 | 2.68M shares 10-Q · filed 2014-08-07 | ||
| 2013-10-28 | 9.00 shares 10-Q · filed 2015-11-05 | 9.00 shares 10-Q · filed 2015-05-11 | ||||
| 2013-09-30 | -9.39M shares derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-13 | 2.67M shares derived: sum of 2 quarters · filed 2014-03-13 | 2.68M shares 10-K · filed 2014-03-13 | |||
| 2013-06-30 | 12.06M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 12.07M shares 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | 9.96K shares 10-Q · filed 2013-05-09 | |||||
| 2011-08-31 | 5.00K shares 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |